XML 22 R13.htm IDEA: XBRL DOCUMENT v3.22.1
Note 7 - Share-based Compensation
3 Months Ended
Mar. 31, 2022
Notes to Financial Statements  
Share-Based Payment Arrangement [Text Block]

(7)

Share-Based Compensation

 

Share-based compensation is measured at the grant date based on the fair value of the award and is recognized as an expense over the requisite service period (generally the vesting period of the equity grant).

 

The Company issues share-based awards through several plans that are described in detail in the notes to the consolidated financial statements for the year ended December 31, 2021.  The compensation cost charged against income for those plans is included in selling, general & administrative expenses as follows (in thousands):

 

  

Three Months Ended

 
  

March 31,

 

Share-based compensation related to:

 

2022

  

2021

 

Common stock grants

 $100  $100 

Stock option grants

  53   53 

Restricted Stock Unit Awards ("RSUs")

  539   348 

Total share-based compensation

 $692  $501 

 

The total income tax benefit recognized in the condensed consolidated statements of income for share-based compensa‐tion arrangements was approximately $381 thousand and $242 thousand for the three-month periods ended March 31, 2022 and 2021, respectively.

 

Common stock grants

 

The compensation expense for common stock granted during the three-month period ended March 31, 2022, was determined based on the market price of the shares on the date of grant.

 

Stock Option grants

 

The following is a summary of stock option activity under all plans for the three-month period ended March 31, 2022:

 

  

Shares Under Options

  

Weighted Average Exercise Price (per share)

  

Weighted Average Remaining Contractual Life (in years)

  

Aggregate Intrinsic Value (in thousands)

 

Outstanding at December 31, 2021

  98,671  $33.53         

Granted

  -             

Exercised

  -             

Outstanding at March 31, 2022

  98,671  $33.53   5.57  $3,221 

Exercisable at March 31, 2022

  87,955  $30.63   5.12  $3,126 

Vested and expected to vest at March 31, 2022

  98,671  $33.53  $5.57  $3,221 

 

During both three-month periods ended March 31, 2022 and 2021, there were no options exercised. At its discretion, the Company allows option holders to surrender previously owned common stock in lieu of paying the exercise price and withholding taxes.  During both the three-month periods ended March 31, 2022 and 2021, no shares were surrendered for this purpose.

 

Restricted Stock Unit awards

 

The following table summarizes information about RSU activity during the three-month period ended March 31, 2021:

 

  

Restricted Stock Units

  

Weighted Average
Grant Date
Fair Value

 

Outstanding at December 31, 2021

  101,168  $41.78 

Awarded

  48,099   74.75 

Shares vested

  (45,785)  39.75 

Shares forfeited

  (21)  74.75 

Outstanding at March 31, 2022

  103,461  $49.19 

 

At the Company’s discretion, upon vesting, RSU holders are given the option to net-share settle to cover the required minimum withholding tax and the remaining amount is converted into the equivalent number of common shares and issued to the RSU holder.  During the three-month periods ended March 31, 2022 and 2021, 19,376 and 14,074 shares were surrendered at an average market price of $67.02 and $52.46, respectively.

 

As of March 31, 2022, the Company had approximately $4.8 million of unrecognized compensation expense that is expected to be recognized over a period of 3 years.